BRAF and melanoma: To assess the role of ITCH in TNFα-triggered BRAF activation, we found that p-MEK and p-ERK were refractory to TNFα treatment in ITCH-depleted melanoma cells (Fig. 4d; Supplementary Fig. 6p).